Neogen Corp (NEOG)
12.02
-0.36
(-2.91%)
USD |
NASDAQ |
Apr 15, 16:00
12.05
+0.03
(+0.25%)
Pre-Market: 08:27
Neogen Revenue (Annual): 822.45M for May 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| May 31, 2023 | 822.45M |
| May 31, 2022 | 527.16M |
| May 31, 2021 | 468.46M |
| May 31, 2020 | 418.17M |
| May 31, 2019 | 414.19M |
| May 31, 2018 | 397.93M |
| May 31, 2017 | 358.28M |
| May 31, 2016 | 321.28M |
| May 31, 2015 | 283.07M |
| May 31, 2014 | 247.40M |
| May 31, 2013 | 207.53M |
| May 31, 2012 | 184.05M |
| May 31, 2011 | 172.68M |
| May 31, 2010 | 140.51M |
| May 31, 2009 | 118.72M |
| May 31, 2008 | 102.42M |
| May 31, 2007 | 86.14M |
| May 31, 2006 | 72.43M |
| Date | Value |
|---|---|
| May 31, 2005 | 62.76M |
| May 31, 2004 | 55.50M |
| May 31, 2003 | 47.68M |
| May 31, 2002 | 41.10M |
| May 31, 2001 | 34.90M |
| May 31, 2000 | 23.51M |
| May 31, 1999 | 22.18M |
| May 31, 1998 | 18.49M |
| May 31, 1997 | 15.30M |
| May 31, 1996 | 12.50M |
| May 31, 1995 | 11.70M |
| May 31, 1994 | 10.70M |
| May 31, 1993 | 7.60M |
| May 31, 1992 | 6.60M |
| May 31, 1991 | 6.00M |
| May 31, 1990 | 6.00M |
| May 31, 1989 | 6.20M |
| May 31, 1988 | 4.80M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
414.19M
Minimum
2019
822.45M
Maximum
2023
530.08M
Average
468.46M
Median
2021
Revenue (Annual) Benchmarks
| Moderna Inc | 6.754B |
| SIGA Technologies Inc | 139.92M |
| Syros Pharmaceuticals Inc | 9.936M |
| Disc Medicine Inc | -- |
| Amylyx Pharmaceuticals Inc | 380.79M |